AzTrials
AzTrials

Sport InjuryNCT06930287

Footwear Difference in Sports Use in Runners With Functional Equinus

An observational study of Sport Injury, run by Universidad Católica de Ávila at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Observational study on Nimbus shoes for daily training with 8mm drop and designed for heavier than normal weight. Shoe weight is 300g with highly structured buttress and upper with internal heat-sealed midfoot for greater lateral stability. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Sport Injury
What is being tested?
250 mg Nimbus shoe
How many people
20 participants
Where
1 siteSpain
Study dates
31 Mar 2025to 30 Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: regular runners with functional standing equine

Who may be able to join

  • patients with functional equine
  • regular runners

Who cannot join

  • patients with severe heterometry (more than 1 cm).
  • Recent lower limb interventions

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jorge Velázquez SAORNIL, PhD. contact

655909940

jvelazquezsa@upsa.es

Spain1 site, 1 recruiting
  • Universidad Pontificia de Salamanca

    Salamanca

    Jorge Velázquez Saornil, PhD., 655909940, jvelazquezsa@upsa.es

    Recruiting

Other trials in Spain

About this study

Official title: Footwear Difference in Sports Use in Runners With Functional Equinus: Observational Study

Observational study on Nimbus shoes for daily training with 8mm drop and designed for heavier than normal weight. Shoe weight is 300g with highly structured buttress and upper with internal heat-sealed midfoot for greater lateral stability. This is a Novablast shoe with a mixed profile for training and competition with 8mm drp and higher midfoot compression range with less lateral containment.

Conditions
Sport Injury
Being tested
250 mg Nimbus shoe
Keywords
halffoot, sports shoe, daily training, competition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 250 mg Nimbus shoeOther

    lightweight shoe

Study groups in NCT06930287
Study groupRoleWhat they receive
300 mg Nimbus shoeNot described
Receives: Other: 250 mg Nimbus shoe

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. functional equine

    footprints measurement with camera and digital goniometer (measured in degrees).

    Measured: 5 weeks

Secondary outcomes (1)
  1. algometry

    pressure pain threshold measured with digital algometer (measured in Newtons).

    Measured: 5 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2025
  2. Study start31 Mar 2025
  3. Primary completion1 Jul 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Prospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06930287
Sponsor's protocol ID
13/12/2024
Status last verified
Apr 2025
First submitted
31 Mar 2025
Last updated
16 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • MacDonald DRW, Neilly D, Littlechild J, Harrold F, Roberts SC. Acute Achilles tendon rupture: Do cast boots produce adequate equinus when used for functional rehabilitation? Foot (Edinb). 2018 Dec;37:1-4. doi: 10.1016/j.foot.2018.07.004. Epub 2018 Oct 12.

    PubMed 30321852
  • DeHeer PA. Equinus and Lengthening Techniques. Clin Podiatr Med Surg. 2017 Apr;34(2):207-227. doi: 10.1016/j.cpm.2016.10.008. Epub 2017 Jan 19.

    PubMed 28257675
  • Rong K, Ge WT, Li XC, Xu XY. Mid-term Results of Intramuscular Lengthening of Gastrocnemius and/or Soleus to Correct Equinus Deformity in Flatfoot. Foot Ankle Int. 2015 Oct;36(10):1223-8. doi: 10.1177/1071100715588994. Epub 2015 Jun 3.

    PubMed 26041542
  • Rodriguez-Sanz D, Losa-Iglesias ME, Becerro de Bengoa-Vallejo R, Palomo-Lopez P, Beltran-Alacreu H, Calvo-Lobo C, Navarro-Flores E, Lopez-Lopez D. Skin temperature in youth soccer players with functional equinus and non-equinus condition after running. J Eur Acad Dermatol Venereol. 2018 Nov;32(11):2020-2024. doi: 10.1111/jdv.14966. Epub 2018 May 18.

    PubMed 29601106
  • Rodriguez-Sanz D, Losa-Iglesias ME, Lopez-Lopez D, Calvo-Lobo C, Palomo-Lopez P, Becerro-de-Bengoa-Vallejo R. Infrared thermography applied to lower limb muscles in elite soccer players with functional ankle equinus and non-equinus condition. PeerJ. 2017 May 25;5:e3388. doi: 10.7717/peerj.3388. eCollection 2017.

    PubMed 28560116
  • Rodriguez-Sanz D, Losa-Iglesias ME, Becerro-de-Bengoa-Vallejo R, Dorgham HAA, Benito-de-Pedro M, San-Antolin M, Mazoteras-Pardo V, Calvo-Lobo C. Thermography related to electromyography in runners with functional equinus condition after running. Phys Ther Sport. 2019 Nov;40:193-196. doi: 10.1016/j.ptsp.2019.09.007. Epub 2019 Sep 25.

    PubMed 31590122

Questions about this trial

What is this clinical trial studying?

An observational study of Sport Injury, run by Universidad Católica de Ávila at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jorge Velázquez SAORNIL, PhD. (655909940, jvelazquezsa@upsa.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

functional equine (time frame: 5 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06930287, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in